ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 51 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2018. The put-call ratio across all filers is 1.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $26,000 | -99.9% | 12,240 | -12.2% | 0.14% | -8.8% |
| Q4 2018 | $31,365,000 | +40633.8% | 13,940 | -36.5% | 0.16% | -52.5% |
| Q3 2018 | $77,000 | +8.5% | 21,940 | 0.0% | 0.34% | -26.9% |
| Q2 2018 | $71,000 | -7.8% | 21,940 | 0.0% | 0.46% | +26.9% |
| Q1 2018 | $77,000 | -24.5% | 21,940 | -4.9% | 0.36% | -16.2% |
| Q4 2017 | $102,000 | +34.2% | 23,073 | +59.1% | 0.43% | +38.6% |
| Q3 2017 | $76,000 | -79.4% | 14,500 | -79.6% | 0.31% | -82.4% |
| Q2 2017 | $369,000 | +103.9% | 70,934 | +66.5% | 1.77% | +101.7% |
| Q1 2017 | $181,000 | +43.7% | 42,600 | +6.5% | 0.88% | +71.0% |
| Q4 2016 | $126,000 | +75.0% | 40,000 | +90.5% | 0.51% | +92.1% |
| Q3 2016 | $72,000 | – | 21,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROW Partners, LLC | 325,000 | $2,077,000 | 1.27% |
| DAFNA Capital Management LLC | 125,000 | $799,000 | 0.82% |
| BARD ASSOCIATES INC | 170,925 | $1,094,000 | 0.46% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 525,000 | $3,355,000 | 0.36% |
| SOPHROSYNE CAPITAL LLC | 42,000 | $267,000 | 0.23% |
| Granite Point Capital Management, L.P. | 205,000 | $1,310,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 407,024 | $2,601,000 | 0.17% |
| SCOGGIN MANAGEMENT LP | 150,000 | $959,000 | 0.08% |
| Geduld E E | 25,000 | $160,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 45,000 | $288,000 | 0.05% |